Structure

Physi-Chem Properties

Molecular Weight:  412.15
Volume:  406.658
LogP:  3.59
LogD:  2.909
LogS:  -4.288
# Rotatable Bonds:  3
TPSA:  83.45
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.83
Synthetic Accessibility Score:  3.928
Fsp3:  0.435
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.82
MDCK Permeability:  3.975501749664545e-05
Pgp-inhibitor:  0.953
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.206
Plasma Protein Binding (PPB):  92.83264923095703%
Volume Distribution (VD):  0.756
Pgp-substrate:  9.02302360534668%

ADMET: Metabolism

CYP1A2-inhibitor:  0.073
CYP1A2-substrate:  0.589
CYP2C19-inhibitor:  0.705
CYP2C19-substrate:  0.852
CYP2C9-inhibitor:  0.755
CYP2C9-substrate:  0.894
CYP2D6-inhibitor:  0.506
CYP2D6-substrate:  0.748
CYP3A4-inhibitor:  0.882
CYP3A4-substrate:  0.725

ADMET: Excretion

Clearance (CL):  6.062
Half-life (T1/2):  0.119

ADMET: Toxicity

hERG Blockers:  0.077
Human Hepatotoxicity (H-HT):  0.305
Drug-inuced Liver Injury (DILI):  0.677
AMES Toxicity:  0.124
Rat Oral Acute Toxicity:  0.775
Maximum Recommended Daily Dose:  0.762
Skin Sensitization:  0.141
Carcinogencity:  0.221
Eye Corrosion:  0.003
Eye Irritation:  0.03
Respiratory Toxicity:  0.168

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC173292

Natural Product ID:  NPC173292
Common Name*:   Dalpanol
IUPAC Name:   n.a.
Synonyms:   Dalpanol
Standard InCHIKey:  UJRXJHPYROZVGI-AQNXPRMDSA-N
Standard InCHI:  InChI=1S/C23H24O7/c1-23(2,25)19-8-13-14(29-19)6-5-11-21(24)20-12-7-16(26-3)17(27-4)9-15(12)28-10-18(20)30-22(11)13/h5-7,9,18-20,25H,8,10H2,1-4H3/t18-,19-,20+/m1/s1
SMILES:  COc1cc2c(cc1OC)OC[C@@H]1[C@H]2C(=O)c2c(O1)c1C[C@@H](Oc1cc2)C(O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL518129
PubChem CID:   182000
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0001607] Rotenoids
          • [CHEMONTID:0003528] Rotenones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[18841906]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota Fruits n.a. n.a. PMID[28075580]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[8326318]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[8350086]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16886 Amorpha fruticosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens ED50 = 0.48 ug ml-1 PMID[469089]
NPT1091 Cell Line RPMI-7951 Homo sapiens ED50 = 4.83 ug ml-1 PMID[469089]
NPT91 Cell Line KB Homo sapiens ED50 = 0.89 ug ml-1 PMID[469089]
NPT81 Cell Line A549 Homo sapiens ED50 = 0.86 ug ml-1 PMID[469089]
NPT672 Cell Line TE-671 Homo sapiens ED50 = 0.49 ug ml-1 PMID[469089]
NPT1864 Cell Line L5178Y Mus musculus IC50 = 700.0 nM PMID[469090]
NPT2 Others Unspecified IC50 = 652.0 nM PMID[469091]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC173292 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9748 High Similarity NPC152477
0.9747 High Similarity NPC128293
0.9679 High Similarity NPC298093
0.9627 High Similarity NPC121333
0.9625 High Similarity NPC242395
0.962 High Similarity NPC273959
0.9565 High Similarity NPC103307
0.95 High Similarity NPC120593
0.9494 High Similarity NPC165549
0.9451 High Similarity NPC156635
0.9444 High Similarity NPC472276
0.9441 High Similarity NPC8965
0.9437 High Similarity NPC234052
0.9383 High Similarity NPC288813
0.9379 High Similarity NPC170245
0.9379 High Similarity NPC235610
0.9375 High Similarity NPC124038
0.9371 High Similarity NPC134783
0.9341 High Similarity NPC473883
0.9329 High Similarity NPC310794
0.9325 High Similarity NPC74559
0.9321 High Similarity NPC477154
0.9321 High Similarity NPC117854
0.9321 High Similarity NPC6588
0.9321 High Similarity NPC150131
0.9317 High Similarity NPC224280
0.9317 High Similarity NPC62261
0.9317 High Similarity NPC300053
0.9317 High Similarity NPC108433
0.9317 High Similarity NPC326520
0.9317 High Similarity NPC472277
0.9313 High Similarity NPC474162
0.9313 High Similarity NPC472448
0.9313 High Similarity NPC83922
0.9313 High Similarity NPC474034
0.9313 High Similarity NPC474033
0.9313 High Similarity NPC81679
0.9313 High Similarity NPC474150
0.9308 High Similarity NPC472624
0.9308 High Similarity NPC471976
0.9304 High Similarity NPC19097
0.9304 High Similarity NPC181960
0.9277 High Similarity NPC67302
0.9268 High Similarity NPC223375
0.9268 High Similarity NPC475825
0.9264 High Similarity NPC177480
0.9259 High Similarity NPC119589
0.9255 High Similarity NPC472281
0.9255 High Similarity NPC236521
0.9255 High Similarity NPC18100
0.9255 High Similarity NPC329669
0.9255 High Similarity NPC473313
0.9255 High Similarity NPC475985
0.9255 High Similarity NPC248638
0.9255 High Similarity NPC152659
0.9255 High Similarity NPC205265
0.9255 High Similarity NPC472278
0.925 High Similarity NPC472632
0.925 High Similarity NPC3629
0.925 High Similarity NPC167678
0.925 High Similarity NPC471210
0.925 High Similarity NPC266314
0.925 High Similarity NPC29876
0.9245 High Similarity NPC95936
0.9245 High Similarity NPC473990
0.9245 High Similarity NPC250214
0.9241 High Similarity NPC303255
0.9207 High Similarity NPC190351
0.9198 High Similarity NPC472450
0.9198 High Similarity NPC275780
0.9198 High Similarity NPC239752
0.9198 High Similarity NPC293319
0.9193 High Similarity NPC261470
0.9193 High Similarity NPC472402
0.9193 High Similarity NPC472635
0.9193 High Similarity NPC220912
0.9193 High Similarity NPC229632
0.9193 High Similarity NPC478199
0.9193 High Similarity NPC25152
0.9187 High Similarity NPC328102
0.9187 High Similarity NPC192686
0.9187 High Similarity NPC119209
0.9187 High Similarity NPC118256
0.9187 High Similarity NPC204290
0.9187 High Similarity NPC174953
0.9187 High Similarity NPC476980
0.9187 High Similarity NPC475784
0.9182 High Similarity NPC475267
0.9182 High Similarity NPC299520
0.9182 High Similarity NPC222814
0.9182 High Similarity NPC469584
0.9182 High Similarity NPC472910
0.9182 High Similarity NPC78225
0.9182 High Similarity NPC474836
0.9182 High Similarity NPC96167
0.9182 High Similarity NPC476981
0.9182 High Similarity NPC223787
0.9182 High Similarity NPC473272
0.9182 High Similarity NPC129684
0.9182 High Similarity NPC472914
0.9182 High Similarity NPC474208
0.9182 High Similarity NPC291508
0.9182 High Similarity NPC99597
0.9182 High Similarity NPC78071
0.9182 High Similarity NPC156057
0.9182 High Similarity NPC245758
0.9182 High Similarity NPC472913
0.9182 High Similarity NPC48208
0.9182 High Similarity NPC162869
0.9182 High Similarity NPC284820
0.9182 High Similarity NPC210084
0.9182 High Similarity NPC262286
0.9182 High Similarity NPC27337
0.9182 High Similarity NPC471209
0.9182 High Similarity NPC36852
0.9182 High Similarity NPC472911
0.9177 High Similarity NPC31018
0.9177 High Similarity NPC37392
0.9177 High Similarity NPC255807
0.9177 High Similarity NPC472909
0.9172 High Similarity NPC40033
0.9172 High Similarity NPC166201
0.9146 High Similarity NPC326877
0.9141 High Similarity NPC39091
0.9141 High Similarity NPC472449
0.9141 High Similarity NPC277480
0.9136 High Similarity NPC41301
0.9136 High Similarity NPC303460
0.9136 High Similarity NPC23298
0.9136 High Similarity NPC186686
0.9136 High Similarity NPC189473
0.9136 High Similarity NPC306321
0.913 High Similarity NPC61010
0.913 High Similarity NPC474038
0.913 High Similarity NPC474187
0.913 High Similarity NPC474186
0.913 High Similarity NPC173137
0.913 High Similarity NPC472275
0.913 High Similarity NPC471212
0.913 High Similarity NPC259456
0.913 High Similarity NPC228383
0.913 High Similarity NPC471211
0.9125 High Similarity NPC204879
0.9125 High Similarity NPC187792
0.9125 High Similarity NPC152904
0.9119 High Similarity NPC235165
0.9119 High Similarity NPC195796
0.9119 High Similarity NPC138243
0.9119 High Similarity NPC191146
0.9119 High Similarity NPC470600
0.9119 High Similarity NPC35038
0.9119 High Similarity NPC472916
0.9119 High Similarity NPC278778
0.9119 High Similarity NPC255106
0.9119 High Similarity NPC68093
0.9119 High Similarity NPC291878
0.9114 High Similarity NPC472408
0.9114 High Similarity NPC472915
0.9114 High Similarity NPC128961
0.9112 High Similarity NPC150977
0.9103 High Similarity NPC238366
0.9091 High Similarity NPC131866
0.9091 High Similarity NPC102277
0.9091 High Similarity NPC279209
0.9085 High Similarity NPC14662
0.9085 High Similarity NPC247973
0.908 High Similarity NPC473286
0.908 High Similarity NPC25361
0.908 High Similarity NPC50960
0.908 High Similarity NPC37183
0.9074 High Similarity NPC52204
0.9074 High Similarity NPC476247
0.9074 High Similarity NPC329760
0.9068 High Similarity NPC200746
0.9068 High Similarity NPC475886
0.9068 High Similarity NPC56085
0.9068 High Similarity NPC228785
0.9068 High Similarity NPC36217
0.9068 High Similarity NPC474287
0.9068 High Similarity NPC14353
0.9062 High Similarity NPC196448
0.9062 High Similarity NPC472598
0.9062 High Similarity NPC474681
0.9062 High Similarity NPC165977
0.9062 High Similarity NPC52889
0.9062 High Similarity NPC474055
0.9062 High Similarity NPC218313
0.9062 High Similarity NPC217677
0.9057 High Similarity NPC230149
0.9057 High Similarity NPC226025
0.9057 High Similarity NPC152951
0.9057 High Similarity NPC256925
0.9057 High Similarity NPC477503
0.9057 High Similarity NPC113906
0.9057 High Similarity NPC168247
0.9057 High Similarity NPC57674
0.9057 High Similarity NPC45849
0.9057 High Similarity NPC200761
0.9057 High Similarity NPC2928
0.9057 High Similarity NPC117992

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC173292 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9679 High Similarity NPD5494 Approved
0.8994 High Similarity NPD2393 Clinical (unspecified phase)
0.8931 High Similarity NPD1934 Approved
0.8875 High Similarity NPD2801 Approved
0.8765 High Similarity NPD3882 Suspended
0.8735 High Similarity NPD6166 Phase 2
0.8735 High Similarity NPD6167 Clinical (unspecified phase)
0.8735 High Similarity NPD6168 Clinical (unspecified phase)
0.8631 High Similarity NPD3818 Discontinued
0.858 High Similarity NPD5844 Phase 1
0.8571 High Similarity NPD4380 Phase 2
0.8529 High Similarity NPD7074 Phase 3
0.8528 High Similarity NPD7096 Clinical (unspecified phase)
0.8476 Intermediate Similarity NPD3817 Phase 2
0.8471 Intermediate Similarity NPD7054 Approved
0.8443 Intermediate Similarity NPD1247 Approved
0.8424 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD7472 Approved
0.8415 Intermediate Similarity NPD7819 Suspended
0.8382 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD7075 Discontinued
0.8364 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD1511 Approved
0.8276 Intermediate Similarity NPD7808 Phase 3
0.8266 Intermediate Similarity NPD6797 Phase 2
0.8263 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8261 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8246 Intermediate Similarity NPD7473 Discontinued
0.8228 Intermediate Similarity NPD1549 Phase 2
0.8225 Intermediate Similarity NPD6959 Discontinued
0.8218 Intermediate Similarity NPD7251 Discontinued
0.8217 Intermediate Similarity NPD2796 Approved
0.821 Intermediate Similarity NPD1512 Approved
0.8182 Intermediate Similarity NPD7411 Suspended
0.8176 Intermediate Similarity NPD6232 Discontinued
0.8165 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD5402 Approved
0.8133 Intermediate Similarity NPD6801 Discontinued
0.8129 Intermediate Similarity NPD3926 Phase 2
0.8114 Intermediate Similarity NPD6559 Discontinued
0.8107 Intermediate Similarity NPD919 Approved
0.8086 Intermediate Similarity NPD6799 Approved
0.8084 Intermediate Similarity NPD1465 Phase 2
0.8057 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD6599 Discontinued
0.7941 Intermediate Similarity NPD3749 Approved
0.7933 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD1510 Phase 2
0.7874 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD2800 Approved
0.7831 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD920 Approved
0.7818 Intermediate Similarity NPD2533 Approved
0.7818 Intermediate Similarity NPD2532 Approved
0.7818 Intermediate Similarity NPD2534 Approved
0.7814 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD7199 Phase 2
0.7802 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1240 Approved
0.7784 Intermediate Similarity NPD3751 Discontinued
0.7778 Intermediate Similarity NPD7768 Phase 2
0.7764 Intermediate Similarity NPD2935 Discontinued
0.7759 Intermediate Similarity NPD3787 Discontinued
0.7725 Intermediate Similarity NPD5403 Approved
0.7714 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD5401 Approved
0.7711 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD37 Approved
0.7702 Intermediate Similarity NPD2799 Discontinued
0.7692 Intermediate Similarity NPD8434 Phase 2
0.7688 Intermediate Similarity NPD1607 Approved
0.7688 Intermediate Similarity NPD6234 Discontinued
0.7684 Intermediate Similarity NPD7228 Approved
0.7674 Intermediate Similarity NPD4967 Phase 2
0.7674 Intermediate Similarity NPD4966 Approved
0.7674 Intermediate Similarity NPD4965 Approved
0.7673 Intermediate Similarity NPD943 Approved
0.7624 Intermediate Similarity NPD8312 Approved
0.7624 Intermediate Similarity NPD8313 Approved
0.7622 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD1243 Approved
0.7619 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD2346 Discontinued
0.759 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD3750 Approved
0.7576 Intermediate Similarity NPD4628 Phase 3
0.7569 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1613 Approved
0.7561 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD3226 Approved
0.7526 Intermediate Similarity NPD6779 Approved
0.7526 Intermediate Similarity NPD6781 Approved
0.7526 Intermediate Similarity NPD6778 Approved
0.7526 Intermediate Similarity NPD6782 Approved
0.7526 Intermediate Similarity NPD6776 Approved
0.7526 Intermediate Similarity NPD6780 Approved
0.7526 Intermediate Similarity NPD6777 Approved
0.7516 Intermediate Similarity NPD447 Suspended
0.7514 Intermediate Similarity NPD7240 Approved
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD8150 Discontinued
0.7485 Intermediate Similarity NPD3748 Approved
0.7458 Intermediate Similarity NPD7229 Phase 3
0.744 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD6100 Approved
0.7439 Intermediate Similarity NPD6099 Approved
0.7438 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD2313 Discontinued
0.7421 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7435 Discontinued
0.7409 Intermediate Similarity NPD7696 Phase 3
0.7409 Intermediate Similarity NPD7697 Approved
0.7409 Intermediate Similarity NPD7698 Approved
0.7407 Intermediate Similarity NPD230 Phase 1
0.7407 Intermediate Similarity NPD1933 Approved
0.7399 Intermediate Similarity NPD6844 Discontinued
0.7396 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD3027 Phase 3
0.7374 Intermediate Similarity NPD2403 Approved
0.7368 Intermediate Similarity NPD1653 Approved
0.7365 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD5953 Discontinued
0.736 Intermediate Similarity NPD5710 Approved
0.736 Intermediate Similarity NPD5711 Approved
0.7358 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD4360 Phase 2
0.7354 Intermediate Similarity NPD4363 Phase 3
0.7349 Intermediate Similarity NPD2424 Discontinued
0.7348 Intermediate Similarity NPD7286 Phase 2
0.7347 Intermediate Similarity NPD7701 Phase 2
0.7333 Intermediate Similarity NPD1551 Phase 2
0.7326 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7783 Phase 2
0.7323 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD2309 Approved
0.7321 Intermediate Similarity NPD6190 Approved
0.7318 Intermediate Similarity NPD5242 Approved
0.7314 Intermediate Similarity NPD5353 Approved
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD8151 Discontinued
0.7308 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD8127 Discontinued
0.7289 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7549 Discontinued
0.7282 Intermediate Similarity NPD7870 Phase 2
0.7282 Intermediate Similarity NPD7871 Phase 2
0.7273 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6823 Phase 2
0.7263 Intermediate Similarity NPD6535 Approved
0.7263 Intermediate Similarity NPD6534 Approved
0.7257 Intermediate Similarity NPD8455 Phase 2
0.7257 Intermediate Similarity NPD5761 Phase 2
0.7257 Intermediate Similarity NPD5760 Phase 2
0.7256 Intermediate Similarity NPD6651 Approved
0.725 Intermediate Similarity NPD2861 Phase 2
0.7241 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD7700 Phase 2
0.724 Intermediate Similarity NPD7699 Phase 2
0.7236 Intermediate Similarity NPD7801 Approved
0.7235 Intermediate Similarity NPD7390 Discontinued
0.7225 Intermediate Similarity NPD7458 Discontinued
0.7208 Intermediate Similarity NPD7584 Approved
0.7195 Intermediate Similarity NPD5124 Phase 1
0.7195 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6355 Discontinued
0.7193 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD2798 Approved
0.7188 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7874 Approved
0.7175 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7033 Discontinued
0.716 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD4665 Approved
0.7157 Intermediate Similarity NPD4111 Phase 1
0.7151 Intermediate Similarity NPD6273 Approved
0.7143 Intermediate Similarity NPD9494 Approved
0.7135 Intermediate Similarity NPD4361 Phase 2
0.7135 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6674 Discontinued
0.7099 Intermediate Similarity NPD6832 Phase 2
0.7098 Intermediate Similarity NPD2974 Approved
0.7098 Intermediate Similarity NPD2975 Approved
0.7098 Intermediate Similarity NPD2973 Approved
0.7091 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1610 Phase 2
0.7087 Intermediate Similarity NPD7907 Approved
0.7083 Intermediate Similarity NPD1471 Phase 3
0.7077 Intermediate Similarity NPD4580 Approved
0.7073 Intermediate Similarity NPD6233 Phase 2
0.7059 Intermediate Similarity NPD4110 Phase 3
0.7059 Intermediate Similarity NPD4109 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data